.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
QuintilesIMS
Federal Trade Commission
UBS
Merck
Cantor Fitzgerald
McKesson
Queensland Health
Teva
AstraZeneca

Generated: December 13, 2017

DrugPatentWatch Database Preview

GALANTAMINE HYDROBROMIDE Drug Profile

« Back to Dashboard

When do Galantamine Hydrobromide patents expire, and what generic alternatives are available?

Galantamine Hydrobromide is a drug marketed by Aurobindo Pharma Ltd, Barr, Impax Labs, Mylan, Sun Pharma Global, Watson Labs, West-ward Pharms Int, Actavis Elizabeth, Apotex Inc, Dr Reddys Labs Ltd, Sandoz, Teva Pharms, Yabao Pharm, and Zydus Pharms Usa Inc. and is included in nineteen NDAs.

The generic ingredient in GALANTAMINE HYDROBROMIDE is galantamine hydrobromide. There are fifteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the galantamine hydrobromide profile page.
Drug patent expirations by year for GALANTAMINE HYDROBROMIDE

Pharmacology for GALANTAMINE HYDROBROMIDE

Medical Subject Heading (MeSH) Categories for GALANTAMINE HYDROBROMIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
SandozGALANTAMINE HYDROBROMIDEgalantamine hydrobromideTABLET;ORAL077589-001Jun 22, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdGALANTAMINE HYDROBROMIDEgalantamine hydrobromideTABLET;ORAL077593-001Sep 11, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntGALANTAMINE HYDROBROMIDEgalantamine hydrobromideTABLET;ORAL077608-003Feb 11, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva PharmsGALANTAMINE HYDROBROMIDEgalantamine hydrobromideTABLET;ORAL077587-002Jul 9, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Yabao PharmGALANTAMINE HYDROBROMIDEgalantamine hydrobromideTABLET;ORAL077604-001Feb 6, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncGALANTAMINE HYDROBROMIDEgalantamine hydrobromideTABLET;ORAL078898-003Feb 17, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdGALANTAMINE HYDROBROMIDEgalantamine hydrobromideTABLET;ORAL090957-003Mar 29, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdGALANTAMINE HYDROBROMIDEgalantamine hydrobromideTABLET;ORAL077593-002Sep 11, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrGALANTAMINE HYDROBROMIDEgalantamine hydrobromideTABLET;ORAL077605-001Aug 28, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdGALANTAMINE HYDROBROMIDEgalantamine hydrobromideCAPSULE, EXTENDED RELEASE;ORAL204895-001Aug 5, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Fish and Richardson
Citi
Harvard Business School
Deloitte
US Army
Chubb
Accenture
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot